Literature DB >> 33514909

From Wingspread to CLARITY: a personal trajectory.

Ana M Soto1, Cheryl M Schaeberle2, Carlos Sonnenschein2.   

Abstract

In the three decades since endocrine disruption was conceptualized at the Wingspread Conference, we have witnessed the growth of this multidisciplinary field and the accumulation of evidence showing the deleterious health effects of endocrine-disrupting chemicals. It is only within the past decade that, albeit slowly, some changes regarding regulatory measures have taken place. In this Perspective, we address some historical points regarding the advent of the endocrine disruption field and the conceptual changes that endocrine disruption brought about. We also provide our personal recollection of the events triggered by our serendipitous discovery of oestrogenic activity in plastic, a founder event in the field of endocrine disruption. This recollection ends with the CLARITY study as an example of a discordance between 'science for its own sake' and 'regulatory science' and leads us to offer a perspective that could be summarized by the motto attributed to Ludwig Boltzmann: "Nothing is more practical than a good theory".

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33514909     DOI: 10.1038/s41574-020-00460-3

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN: 1759-5029            Impact factor:   47.564


  108 in total

Review 1.  Intrauterine position effects.

Authors:  Bryce C Ryan; John G Vandenbergh
Journal:  Neurosci Biobehav Rev       Date:  2002-10       Impact factor: 8.989

Review 2.  Regulation of cell proliferation: the negative control perspective.

Authors:  A M Soto; C Sonnenschein
Journal:  Ann N Y Acad Sci       Date:  1991       Impact factor: 5.691

3.  Human serum albumin shares the properties of estrocolyone-I, the inhibitor of the proliferation of estrogen-target cells.

Authors:  C Sonnenschein; A M Soto; C L Michaelson
Journal:  J Steroid Biochem Mol Biol       Date:  1996-10       Impact factor: 4.292

Review 4.  TRIENNIAL REPRODUCTION SYMPOSIUM: Environmental programming of reproduction during fetal life: Effects of intrauterine position and the endocrine disrupting chemical bisphenol A.

Authors:  F S Vom Saal
Journal:  J Anim Sci       Date:  2016-07       Impact factor: 3.159

5.  Increased occurrence of autoimmune disease among women exposed in utero to diethylstilbestrol.

Authors:  K L Noller; P B Blair; P C O'Brien; L J Melton; J R Offord; R H Kaufman; T Colton
Journal:  Fertil Steril       Date:  1988-06       Impact factor: 7.329

6.  Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women.

Authors:  A L Herbst; H Ulfelder; D C Poskanzer
Journal:  N Engl J Med       Date:  1971-04-15       Impact factor: 91.245

7.  Exposure to environmentally relevant doses of the xenoestrogen bisphenol-A alters development of the fetal mouse mammary gland.

Authors:  Laura N Vandenberg; Maricel V Maffini; Perinaaz R Wadia; Carlos Sonnenschein; Beverly S Rubin; Ana M Soto
Journal:  Endocrinology       Date:  2006-10-05       Impact factor: 4.736

Review 8.  The biological default state of cell proliferation with variation and motility, a fundamental principle for a theory of organisms.

Authors:  Ana M Soto; Giuseppe Longo; Maël Montévil; Carlos Sonnenschein
Journal:  Prog Biophys Mol Biol       Date:  2016-07-02       Impact factor: 3.667

Review 9.  Developmental effects of endocrine-disrupting chemicals in wildlife and humans.

Authors:  T Colborn; F S vom Saal; A M Soto
Journal:  Environ Health Perspect       Date:  1993-10       Impact factor: 9.031

10.  p-Nonyl-phenol: an estrogenic xenobiotic released from "modified" polystyrene.

Authors:  A M Soto; H Justicia; J W Wray; C Sonnenschein
Journal:  Environ Health Perspect       Date:  1991-05       Impact factor: 9.031

View more
  1 in total

1.  Scientific discrepancies in European regulatory proposals on endocrine disruptors-REACH regulation quo vadis?

Authors:  Andreas Natsch
Journal:  Arch Toxicol       Date:  2021-09-10       Impact factor: 5.153

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.